LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 46 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,484,000 | -27.2% | 465,247 | -2.6% | 0.01% | 0.0% |
| Q1 2022 | $2,038,000 | +0.7% | 477,688 | +9.7% | 0.01% | 0.0% |
| Q4 2021 | $2,023,000 | +37.9% | 435,387 | +18.3% | 0.01% | +33.3% |
| Q3 2021 | $1,467,000 | +7.0% | 368,168 | +14.9% | 0.01% | +20.0% |
| Q2 2021 | $1,371,000 | +181.5% | 320,392 | +178.7% | 0.01% | +150.0% |
| Q1 2021 | $487,000 | -59.0% | 114,946 | -58.8% | 0.00% | -60.0% |
| Q2 2020 | $1,187,000 | +889.2% | 278,664 | +879.5% | 0.01% | +400.0% |
| Q1 2020 | $120,000 | -26.4% | 28,449 | -31.7% | 0.00% | 0.0% |
| Q4 2019 | $163,000 | +805.6% | 41,626 | +6414.2% | 0.00% | – |
| Q3 2015 | $18,000 | -18.2% | 639 | -27.4% | 0.00% | – |
| Q2 2015 | $22,000 | – | 880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |